Moderna's on the Rise, but This Small Biotech Is the Nasdaq's Big Winner on New Year's Eve
2021 is drawing to a close, and Wall Street is ending the year with a whimper. Stock market indexes are modestly lower, with the Nasdaq Composite (NASDAQINDEX: ^IXIC) falling 0.2% as of noon ET.
As COVID-19 case counts have soared, investors have watched with interest to see the potential impact on companies that have fought hardest against the pandemic. Vaccine maker Moderna (NASDAQ: MRNA) picked up some ground on Friday, as investors anticipated that greater interest in COVID-19 vaccines and boosters could continue well into 2022. However, another stock in the biotech arena had much larger gains. Read on to find out more about it, as well as about Moderna's prospects going forward.
Image source: Getty Images.
Source Fool.com
